Categories NFU FDA approves remdesevir as “first drug for COVID-19,” despite WHO trial showing no benefit Post author By MCM Post date October 22, 2020 No Comments on FDA approves remdesevir as “first drug for COVID-19,” despite WHO trial showing no benefit Another way to bury HCQ. (Thank you, Pres. Trump!) Article link: https://www.medpagetoday.com/infectiousdisease/covid19/89281 ← Flu shots have now claimed the lives of 28 South Koreans → Boston University requiring “digital badges” to enter campus buildings Leave a ReplyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.